Newsfeed

Every published oncology item from an approved source, most recent first. No account required — this is the unfiltered stream, not personalized to any follows.

Items are tagged with the biomarkers and tumour types they resolve to; each tag opens that record, and every record’s page carries the same items back.

This demo serves a captured snapshot of the feed, not a live connection to the sources.

PubMed Central · Jul 28, 2026
Negatively Charged Peptides-Assisted Self-Assembled Mitochondria-Targeting Nanoprobe for Detecting Enterokinase and Image-Guided Navigation in Human Breast Cancer.
- breast cancer (tumour type)
Read at PubMed Central
PubMed Central · Jul 27, 2026
DNA methylation profiling enables subclassification of mucinous ovarian carcinoma and distinguishes it from extraovarian mucinous metastases.
- ovarian cancer (tumour type)
Read at PubMed Central
PubMed Central · Jul 27, 2026
SKYSCRAPER-01: Tiragolumab in Combination With Atezolizumab in Previously Untreated PD-L1-High, Locally Advanced, Unresectable or Metastatic Non-Small Cell Lung Cancer.
- PD-L1 (biomarker)
- non-small cell lung cancer (tumour type)
Read at PubMed Central
PubMed Central · Jul 25, 2026
Thioredoxin interacting protein (TXNIP), a redox regulator, mediates the EPAC-RAP1 signaling dependency of primary melanoma.
- melanoma (tumour type)
Read at PubMed Central
PubMed Central · Jul 24, 2026
Combine antibody-drug conjugate with cmLumiOpto for triple-negative breast cancer treatment.
- breast cancer (tumour type)
- triple-negative breast cancer (tumour type)
Read at PubMed Central
PubMed Central · Jul 24, 2026
Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).
- ERBB2 (biomarker)
- breast cancer (tumour type)
Read at PubMed Central
PubMed Central · Jul 24, 2026
Autocrine CysLT(1)R-ERK/YAP signaling drives melanoma progression and reveals a targetable oncogenic GPCR axis.
- melanoma (tumour type)
Read at PubMed Central
PubMed Central · Jul 24, 2026
Multidimensional molecular mechanisms of drug resistance in breast cancer: Implications for clinical decision‑making and treatment strategies (Review).
- breast cancer (tumour type)
Read at PubMed Central
PubMed Central · Jul 23, 2026
Driving tumor-associated macrophages to a CXCL9(Hi)/SPP1(Low) phenotype eliminates pancreatic cancer.
- pancreatic cancer (tumour type)
Read at PubMed Central
PubMed Central · Jul 22, 2026
Brown bullhead catfish melanoma represents a novel transmissible cancer.
- melanoma (tumour type)
Read at PubMed Central
PubMed Central · Jul 21, 2026
Differences in the Gastric Microbiotas of Neighboring Populations With Divergent Risks of Gastric Cancer.
- gastric cancer (tumour type)
Read at PubMed Central
PubMed Central · Jul 21, 2026
Brazilian Society of Surgical Oncology Analysis in Cost-Effectiveness of Population-Based BRCA Testing for Ovarian Cancer in the Public Health System.
- ovarian cancer (tumour type)
Read at PubMed Central
PubMed Central · Jul 20, 2026
Comparison of minimally invasive surgery and open surgery following chemotherapy for cStage IVb gastric cancer: a multicenter retrospective cohort study.
- gastric cancer (tumour type)
Read at PubMed Central
PubMed Central · Jul 20, 2026
Splicing-mediated control of hnRNPD isoform switching by SRSF2 drives PD-L1-dependent immune evasion in gallbladder cancer.
- PD-L1 (biomarker)
Read at PubMed Central
PubMed Central · Jul 20, 2026
Hepatic origin of increased serum TFF3 in gastric cancer bearing subjects.
- gastric cancer (tumour type)
Read at PubMed Central
PubMed Central · Jul 17, 2026
The neural stem cell‑NSCLC axis: Molecular drivers, microenvironment crosstalk and emerging therapies (Review).
- non-small cell lung cancer (tumour type)
Read at PubMed Central
PubMed Central · Jul 17, 2026
Immunoediting and precision biomarkers in prostate cancer: The emerging role of liquid biopsy, immune contexture and HLA genotype (Review).
- prostate cancer (tumour type)
Read at PubMed Central
PubMed Central · Jul 17, 2026
YAP1‑mediated cytoplasmic‑nuclear translocation of SREBP2 promotes colorectal cancer via regulation of cholesterol metabolism.
- colorectal cancer (tumour type)
Read at PubMed Central
PubMed Central · Jul 17, 2026
[Expression of Concern] Chrysophanol inhibits proliferation and induces apoptosis through NF‑κB/cyclin D1 and NF‑κB/Bcl‑2 signaling cascade in breast cancer cell lines.
- breast cancer (tumour type)
Read at PubMed Central
PubMed Central · Jul 16, 2026
Epigenomic profiling links IGF2 overexpression to anthracycline resistance in colorectal cancer organoids.
- colorectal cancer (tumour type)
Read at PubMed Central

Newsfeed

Negatively Charged Peptides-Assisted Self-Assembled Mitochondria-Targeting Nanoprobe for Detecting Enterokinase and Image-Guided Navigation in Human Breast Cancer.

DNA methylation profiling enables subclassification of mucinous ovarian carcinoma and distinguishes it from extraovarian mucinous metastases.

SKYSCRAPER-01: Tiragolumab in Combination With Atezolizumab in Previously Untreated PD-L1-High, Locally Advanced, Unresectable or Metastatic Non-Small Cell Lung Cancer.

Thioredoxin interacting protein (TXNIP), a redox regulator, mediates the EPAC-RAP1 signaling dependency of primary melanoma.

Combine antibody-drug conjugate with cmLumiOpto for triple-negative breast cancer treatment.

Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).

Autocrine CysLT(1)R-ERK/YAP signaling drives melanoma progression and reveals a targetable oncogenic GPCR axis.

Multidimensional molecular mechanisms of drug resistance in breast cancer: Implications for clinical decision‑making and treatment strategies (Review).

Driving tumor-associated macrophages to a CXCL9(Hi)/SPP1(Low) phenotype eliminates pancreatic cancer.

Brown bullhead catfish melanoma represents a novel transmissible cancer.

Differences in the Gastric Microbiotas of Neighboring Populations With Divergent Risks of Gastric Cancer.

Brazilian Society of Surgical Oncology Analysis in Cost-Effectiveness of Population-Based BRCA Testing for Ovarian Cancer in the Public Health System.

Comparison of minimally invasive surgery and open surgery following chemotherapy for cStage IVb gastric cancer: a multicenter retrospective cohort study.

Splicing-mediated control of hnRNPD isoform switching by SRSF2 drives PD-L1-dependent immune evasion in gallbladder cancer.

Hepatic origin of increased serum TFF3 in gastric cancer bearing subjects.

The neural stem cell‑NSCLC axis: Molecular drivers, microenvironment crosstalk and emerging therapies (Review).

Immunoediting and precision biomarkers in prostate cancer: The emerging role of liquid biopsy, immune contexture and HLA genotype (Review).

YAP1‑mediated cytoplasmic‑nuclear translocation of SREBP2 promotes colorectal cancer via regulation of cholesterol metabolism.

[Expression of Concern] Chrysophanol inhibits proliferation and induces apoptosis through NF‑κB/cyclin D1 and NF‑κB/Bcl‑2 signaling cascade in breast cancer cell lines.

Epigenomic profiling links IGF2 overexpression to anthracycline resistance in colorectal cancer organoids.